Top Contract Research Organizations (CROs)

Wednesday, September 09, 2026

CMMS and EAM software have become an important part of asset management across the life sciences industry, where equipment reliability, maintenance records and regulatory discipline directly influence operations. Pharmaceutical plants, biotechnology facilities, laboratories and medical manufacturing sites depend on controlled environments and specialized assets that cannot be managed through reactive maintenance alone. These platforms help organizations plan work, track equipment history, manage spare parts and document maintenance activity in a structured way. Their business value extends beyond reducing downtime, supporting compliance, better capital planning and more consiste

Tuesday, September 08, 2026

Fremont, CA: Healthcare providers are placing greater emphasis on chronic weight management therapy as treatment approaches become more structured and personalized to address the complex factors influencing long-term weight management. Clinical teams are increasingly coordinating medical evaluation, behavioral support, nutritional guidance and progress assessment to develop individualized care pathways that respond to changing patient needs. This integrated approach is encouraging more consistent treatment planning while strengthening collaboration among multidisciplinary healthcare professionals involved in long-term care. Clinical challenges regarding chronic

Friday, October 24, 2025

• IND opening marks culmination of partnership between Dewpoint and Evotec, advancing a de novo development candidate through IND-enabling studies • First patient dosing planned before year-end 2025 at leading cancer centers in collaboration with top key opinion leaders • Program validates Dewpoint’s condensate-modulator discovery platform and the value of agile, integrated partnerships in accelerating novel drug development. Boston, Mass – Dewpoint Therapeutics today announced the opening of an Investigational New Drug (IND) application to the U

Tuesday, September 30, 2025

Service providers are fundamentally reengineering clinical trials by implementing innovative methodologies that accelerate study design and execution. They are moving the industry beyond rigid, traditional frameworks by championing adaptive trial models, pioneering decentralized protocols, and seamlessly integrating real-world data into their approaches. This transformation is making clinical research more efficient, patient-centric, and capable of delivering therapeutic breakthroughs faster than ever before. The Rise of Adaptive Trial Models The paradigm of clinical research is undergoing a profound evolution, moving away from the static, one-size-fit

Friday, March 14, 2025

The landscape of Contract Research Organization (CRO) services in European drug discovery is undergoing a significant transformation, driven by advancements in bioproduction tools. These innovations are streamlining processes, enhancing efficiency, and ultimately accelerating the development of novel therapeutics. Key Bioproduction Innovations and Their Impact The bioproduction landscape is transforming, driven by innovations that enhance efficiency, reduce costs, and ensure compliance with stringent regulatory requirements. Among these advancements, single-use systems (SUS) have transformed bioprocessing by eliminating extensive cleaning and sterilisa

Wednesday, October 23, 2024

● New knowledgebase with expert-curated pharmacogenomic content on how genetic variations influence drug response ● Centralized data and automated annotation enable scientific and translational researchers to rapidly generate genomic and drug insights ● Enhancing the understanding of pharmacogenomics is crucial to, reduce treatment-related side effects and optimizing drug development and delivery Redwood City, California – QIAGEN Digital Insights (QDI), the bioinformatics business of QIAGEN and the leading provider of bioinformatics software and biomedical know